Wnt7b Inhibits Osteoclastogenesis via AKT Activation and Glucose Metabolic Rewiring.
Ontology highlight
ABSTRACT: The imbalance between bone formation and bone resorption causes osteoporosis, which leads to severe bone fractures. It is known that increases in osteoclast numbers and activities are the main reasons for increasing bone resorption. Although extensive studies have investigated the regulation of osteoclastogenesis of bone marrow macrophages (BMMs), new pharmacological avenues still need to be unveiled for clinical purpose. Wnt ligands have been widely demonstrated as stimulators of bone formation; however, the inhibitory effect of the Wnt pathway in osteoclastogenesis is largely unknown. Here, we demonstrate that Wnt7b, a potent Wnt ligand that enhances bone formation and increases bone mass, also abolishes osteoclastogenesis in vitro. Importantly, enforced expression of Wnt in bone
SUBMITTER: Wu F
PROVIDER: S-EPMC8645835 | biostudies-literature | 2021
REPOSITORIES: biostudies-literature
ACCESS DATA